Qian, Xuyu https://orcid.org/0000-0001-5944-3816
Coleman, Kyle
Jiang, Shunzhou https://orcid.org/0009-0000-7309-2389
Kriz, Andrea J.
Marciano, Jack H. https://orcid.org/0000-0002-0238-9916
Luo, Chunyu https://orcid.org/0009-0004-7047-0857
Cai, Chunhui
Manam, Monica Devi
Caglayan, Emre https://orcid.org/0000-0001-5340-8614
Lai, Abbe
Exposito-Alonso, David https://orcid.org/0000-0002-4950-2744
Otani, Aoi
Ghosh, Urmi
Shao, Diane D. https://orcid.org/0000-0003-2087-4082
Andersen, Rebecca E. https://orcid.org/0000-0002-0702-3120
Neil, Jennifer E.
Johnson, Robert
LeFevre, Alexandra
Hecht, Jonathan L.
Micali, Nicola https://orcid.org/0009-0002-2936-4708
Sestan, Nenad https://orcid.org/0000-0003-0966-9619
Rakic, Pasko https://orcid.org/0000-0002-6963-0508
Miller, Michael B. https://orcid.org/0000-0002-6205-3314
Sun, Liang
Stringer, Carsen https://orcid.org/0000-0002-9229-4100
Li, Mingyao https://orcid.org/0000-0001-8180-0621
Walsh, Christopher A. https://orcid.org/0000-0002-0156-2238
Article History
Received: 22 May 2024
Accepted: 4 April 2025
First Online: 14 May 2025
Competing interests
: C.A.W. has stock ownership in Maze Therapeutics and Mosaica Therapeutics, and is a paid consultant for Third Rock Ventures and Flagship Pioneering. M.L. receives research funding from Biogen, unrelated to the current article. M.L. is a co-founder of OmicPath AI. The remaining authors declare no competing interests.